News
-
Researchers Wrestle with Accuracy of AI Technology Used to Create New Drug Candidates
The UNC School of Medicine lab of Bryan Roth, MD, PhD, and colleagues at UCSF, Stanford and Harvard determined that a protein prediction technology can yield accurate results in the hunt to efficiently find the best possible drug candidates for many conditions. Original article can be found here.
-
Scientists Discover Surprising Details about Xylazine in Combination with Fentanyl
The UNC School of Medicine lab of Zoe McElligott, PhD, and colleagues found that the animal tranquilizer xylazine activates opioid receptors in the brain, suggesting a reason why the treatment naloxone triggers a more severe withdrawal response when given to individuals on fentanyl/xylazine and suffering from respiratory depression. Original article can be found here.
-
Researchers Discover How We Perceive Bitter Taste
A new study in the lab of Bryan Roth, MD, PhD, at the UNC School of Medicine, helps us better understand how we perceive bitter taste on a chemical level. The findings may lead to the development of drugs that targeting taste receptors. Full article can be found here.
-
Researchers Show How Neurochemicals Affect fMRI Readings
A landmark study, led by Yen-Yu Ian Shih, PhD, professor of neurology and associate director of UNC’s Biomedical Research Imaging Center, could alter how researchers interpret results from functional magnetic resonance imaging. Original article can be found here.
-
Hahn Awarded CZI Grant to Monitor, Manipulate Proteins Important in Nervous System Function, Neurological Disease
Klaus Hahn, PhD, the Ronald G. Thurman Distinguished Professor of Pharmacology at the UNC School of Medicine, will co-lead this Chan Zuckerberg Initiative project with colleagues at Duke University and North Carolina State University. Full article found here.